SCHEMBL21701474

SCHEMBL21701474

O=C(Nc1ccc(N2CCNCC2)cc1C(=O)O)c1ccco1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.58
▸ CYP1A2 P05177 2/20 0.51
▸ MAPT P10636 4/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ GAA P10253 2/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ NPC1 O15118 3/20 0.47
▸ RAB9A P51151 3/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ PKM P14618 1/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ TP53 P04637 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21701591 0.84 SMN1; SMN2 (0.55) SMN1; SMN2CYP1A2MAPTALDH1A1GAA
SCHEMBL21701579 0.81 SMN1; SMN2 (0.53) SMN1; SMN2CYP1A2MAPTALDH1A1GAA
SCHEMBL21683001 0.81 ALDH1A1 (0.56) SMN1; SMN2CYP1A2MAPTALDH1A1GAA
SCHEMBL21701587 0.79 ALDH1A1 (0.53) SMN1; SMN2CYP1A2MAPTALDH1A1GAA
SCHEMBL13460198 0.77 USP2 (0.47) CYP1A2MAPTALDH1A1CYP3A4CYP2C9
SCHEMBL6815137 0.74 GFER (0.71) SMN1; SMN2CYP1A2MAPTALDH1A1GAA
SCHEMBL14075179 0.74 LTC4S (0.66) SMN1; SMN2CYP1A2GAANPC1RAB9A
SCHEMBL21701478 0.74 CYP1A2 (0.61) SMN1; SMN2CYP1A2MAPTALDH1A1GAA
SCHEMBL6933566 0.74 CYP1A2 (0.61) SMN1; SMN2CYP1A2MAPTALDH1A1GAA
SCHEMBL6814636 0.74 CYP1A2 (0.57) CYP1A2MAPTALDH1A1GAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020033944-A2 NON-POLYAMINE BASED POLYAMINE TRANSPORT INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN CANCERS UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2020-02-13 — — WO disclosed
Send feedback